Original Research

Comparing Artificial Intelligence Platforms for Histopathologic Cancer Diagnosis

Author and Disclosure Information

 

References

Conclusion

We have demonstrated the successful application of 2 readily available ML platforms in providing diagnostic guidance in differentiation between common cancer conditions in veteran patient populations. Although both platforms performed very well with no statistically significant differences in results, some distinctions are worth noting. Apple Create ML can be used on local computers but is limited to an Apple operating system. Google AutoML is not platform-specific but runs only via Google Cloud with associated computational fees. Using these readily available models, we demonstrated the vast potential of AI in diagnostic pathology. The application of AI to clinical medicine remains in the very early stages. The VA is uniquely poised to provide leadership as AI technologies will continue to dramatically change the future of health care, both in veteran and nonveteran patients nationwide.

Acknowledgments

The authors thank Paul Borkowski for his constructive criticism and proofreading of this manuscript. This material is the result of work supported with resources and the use of facilities at the James A. Haley Veterans’ Hospital.

Pages

Recommended Reading

Putting Research Into Real-Life Practice
AVAHO
Shulkin Nominated to Replace McDonald at VA
AVAHO
VA Program Rewards Innovators and Best Practices
AVAHO
New NCI Formulary May Help Streamline Cancer Clinical Trials
AVAHO
Criteria for Use Updates for Enzalutamide, Daratumumab, Elotuzumab, Carfilzomib, and Ixazomib (FULL)
AVAHO
Shulkin: Privatization Fight Led to Ouster
AVAHO
Breaking News: Trump Upends Federal Pay for 2019
AVAHO
President Trump calls for end to HIV/AIDS, pediatric cancer
AVAHO
Cloud of inconsistency hangs over cannabis data
AVAHO
Electronic health records linked to lower patient safety
AVAHO

Related Articles